AstraZenea’s 3-in-1 COPD inhaler Breztri gets FDA green light to play catch-up with GSK’s Trelegy

AstraZenea’s 3-in-1 COPD inhaler Breztri gets FDA green light to play catch-up with GSK’s Trelegy
aliu
Fri, 07/24/2020 – 11:04